Skip to main content
OpenTrials

Clinical trial condition

Hyperoxaluria

Explore clinical trials studying Hyperoxaluria. Study availability and eligibility vary by location and protocol.

36 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Hyperoxaluria trial results

Recruiting

Rare Kidney Stone Consortium Patient Registry

NCT00588562

Conditions
APRT Deficiency, Adenine phosphoribosyltransferase deficiency, Carbohydrate Metabolism, Inborn Errors, +19 more
Locations
  • Dent Disease Registry -Mayo Clinic Rochester, Minnesota, United States
  • Primary Hyperoxaluria Registry - Mayo Clinic Rochester, Minnesota, United States
  • Cystinuria Registry - New York University New York, United States
  • APRT Registry - Landspitali Universtiy Hospital Reykjavik, Iceland
View Trial Details
Recruiting

Monogenic Kidney Stone - Genetic Testing

NCT03305835

Conditions
Adenine phosphoribosyltransferase deficiency, Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Recruiting

Prospective Research Rare Kidney Stones (ProRKS)

NCT02780297

Conditions
Abnormalities, Multiple, Adenine Phosphoribosyltransferase Deficiency, Adenine phosphoribosyltransferase deficiency, +28 more
Locations
  • University of Alabama @ Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Children's Memorial Hospital Chicago, Illinois, United States
  • Children's Hospital, Harvard Medical School Boston, Massachusetts, United States
View Trial Details
Completed

A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1

NCT04152200

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +14 more
Locations
  • Clinical Trial Site Rochester, Minnesota, United States
  • Clinical Trial Site Houston, Texas, United States
  • Clinical Trial Site Garran, Australia
  • Clinical Trial Site Brussels, Belgium
View all 14 locations
View Trial Details

Related conditions